Targeting cell cycle-regulatory and proto-oncogenic signaling pathways, including Notch, Wnt, NF-κB, Sonic Hedgehog (SHH), ER, PI3K/Akt/mTOR, and HER2, has become an emerging area in cancer research [7]. This evidence concerns the gene ERBB2 and cancer.